![Jeffrey James Roix](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey James Roix
Director Ejecutivo en
Stingray Bio Ltd.
.
Perfil
Jeffrey James Roix currently works at Stingray Bio Ltd., as Chief Executive Officer, Opal Therapeutics Ltd., as Director from 2021, and o2h Ltd, as Venture Partner from 2020.
Mr. Roix also formerly worked at NeoPhore Ltd., as Chief Executive Officer & Director and PhoreMost Ltd., as Chief Operating Officer from 2015 to 2018.
Mr. Roix received his undergraduate degree from Harvard Extension School.
Cargos activos de Jeffrey James Roix
| Empresas | Cargo | Inicio |
|---|---|---|
Stingray Bio Ltd.
 Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Director Ejecutivo | - |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Inversor de Capital Privado | 01/07/2020 |
Opal Therapeutics Ltd.
 Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Director/Miembro de la Junta | 01/03/2021 |
Antiguos cargos conocidos de Jeffrey James Roix.
| Empresas | Cargo | Fin |
|---|---|---|
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Director de Operaciones | 01/04/2018 |
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Director Ejecutivo | - |
Formación de Jeffrey James Roix.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhoreMost Ltd.
PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
Opal Therapeutics Ltd.
Opal Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
NeoPhore Ltd.
NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of small molecules inhibitors to treat cancer | Commercial Services |
Stingray Bio Ltd.
Stingray Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research services | Commercial Services |
- Bolsa de valores
- Insiders
- Jeffrey James Roix
